Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions

Annals of Pharmacotherapy

Volumn 43, Issue 4, 2009, Pages 707-713

  Wine, Jessica N ^a   Sanda, Christina ^a   Caballero, Joshua ^b,c  

^a Miami Veterans Affairs Healthcare System   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c University of Miami Jackson Memorial Medical Center   (United States)

Author keywords

Insomnia; Quetiapine; Sleep

Indexed keywords

CHLORPROMAZINE; ESCITALOPRAM; OLANZAPINE; PEROSPIRONE; PLACEBO; QUETIAPINE; RISPERIDONE; VENLAFAXINE;

AGITATION; AKATHISIA; ARTICLE; BEDTIME DOSAGE; BIPOLAR DISORDER; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; CLINICAL TRIAL; DIABETES MELLITUS; DROWSINESS; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; HUMAN; INSOMNIA; LEG MOVEMENT; MAJOR DEPRESSION; MENTAL DISEASE; METABOLIC DISORDER; PARKINSON DISEASE; PERIODIC LEG MOVEMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REM SLEEP; RESPIRATORY FAILURE; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP PARAMETERS; SLEEP TIME; SLEEP WALKING; SOMNOLENCE; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; WEIGHT GAIN; XEROSTOMIA;

ANIMALS; DIBENZOTHIAZEPINES; HUMANS; MENTAL DISORDERS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 65749097422     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L320     Document Type: Article

References (20)

1. Roth T. Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry 2005;66(suppl):S10-3.
2. Cohrs S, Rodenbeck A, Guan Z, et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 2004;174:421-9. DOI 10.1007/s00213-003-1759-5
3. Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry 2008;20:15-20. DOI 10.1080/10401230701866870
4. Cohrs S, Pohlmann K, Guan Z, et al. Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology 2004;174:414-20. DOI 10.1007/s00213-003-1766-6
5. Wiegand MH, Landry F, Bruckner T, Pohl C, Vesely Z, Jahn T. Quetiapine in primary insomnia: a pilot study. Psychopharmacology 2008;196:337-8. DOI 10.1007/s00213-007-0968-8
6. Fernando A, Chew G. Chronic insomnia secondary to chronic pain responding to quetiapine (letter). Australas Psychiatry 2005;13:86. (Pubitemid 40514994)
7. Keshavan MS, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry 1990;31:34-47. (Pubitemid 20065981)
8. Keshavan MS, Prasad KM, Montrose DM, Miewald JM, Kupfer DJ. Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients (letter). J Clin Psychopharmacol 2007;27:703-705
9. Yamashita H, Mori K, Nagao M, Okamoto Y, Morinobu S, Yamawaki S. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population. J Clin Psychiatry 2004;65:1525-1530
10. Yamashita H, Mori K, Nagao M, Okamoto Y, Morinobu S, Yamawaki S. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults. Am J Geriatr Psychiatry 2005;13:377-384 (Pubitemid 40617480)
11. Endicott J, Paulsson B, Gustafsson U, Schioler H, Hassan M. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep. J Affect Disord 2008;111:306-319
12. Todder D, Caliskan S, Baune BT. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. J Clin Psychopharmacol 2006;26:638-642 DOI 10.1097/01.jcp.0000239798.59943.77
13. Sokolski KN, Brown BJ. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine. Ann Pharmacother 2006;40:567-570 Epub 14 Feb 2006. DOI 10.1345/aph.1G416
14. Robert S, Hamner MB, Kose S, Ulmer HG, Deitsch SE, Lorberbaum JP. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol 2005;25:387-388 (Pubitemid 41060262)
15. Juri C, Chana P, Tapia J, Kunstmann C, Parrao T. Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol 2005;28:185-187 (Pubitemid 41134246)
16. Product information. Seroquel (quetiapine fumarate). www1astrazenecauscom/pi/Seroquelpdf (accessed 30 May 2008).
17. Twaites BR, Wilton LV, Shakir SA. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England. J Psychopharmacol 2007;21:392-399 DOI 10.1177/0269881107073257
18. Freudenmann RW, Sussmuth SD, Wolf RC, Stiller P, Schonfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry 2008;41:119-121
19. Catalano G, Grace JW, Catalano MC, Morales MJ, Cruse LM. Acute akathisia associated with quetiapine use. Psychosomatics 2005;46:291-301. (Pubitemid 41472627)
20. Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr 2007;12:910-912